BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 6, 2007
View Archived Issues
Regeneron's Antibody Platform Draws $120M In First License
Regeneron Pharmaceuticals Inc. unveiled the first licensing deal for what it believes is a revolutionary antibody discovery technology, a nonexclusive agreement with a guarantee of $80 million. (Bioworld Today)
Read More
Deal-Making Competition Is Up; Winners Offer More Than Money
Read More
Researchers Share Strategies To Avoid Getting Lost In Translation
Read More
Bush Proposes To Up FDA Budget In Next Fiscal Year
Read More
Wyeth's Pair Of Hemophilia Deals Target Longer Action
Read More
Columbia Labs Plunges On Prochieve Phase III Failure
Read More
Enzo Brings In $15M For Various Clinical Programs
Read More
Other News To Note
Read More
Clinic Roundup
Read More